Bank Norwegian AS
11.3.2021 11:46:37 CET | Globenewswire | Press release
Bank Norwegian AS refers to the announcement on 8 March 2021. The bank has today conducted buybacks in BANKN22 and BANKN23 with the following terms:
SEK 40 million in BANKN22 (ISIN NO0010848583) at 100.589 equal to 3 months STIBOR + 0.30%
NOK 381 million in BANKN23 (ISIN NO0010848591) at 101.048 equal to 3 months NIBOR + 0.50%
The settlement date is 18 March 2021. BANKN23 will be retained on the issuers own book. Outstanding amount in BANKN22 will be reduced with SEK 40 million to SEK 152 million.
Contact persons:
CFO Klara-Lise Aasen; phone +47 47 63 55 83; kaa@banknorwegian.no
Head of treasury Mats Benserud; phone +47 95 89 15 39; mbe@banknorwegian.no
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Ingredion Incorporated18.9.2026 00:05:21 CEST | Press release
Ingredion Incorporated Increases Quarterly Dividend to $0.83 Per Share
Biogen Inc.17.9.2026 22:15:00 CEST | Press release
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
Chint Global17.9.2026 21:05:04 CEST | Press release
CHINT Presents Advanced Grid Solutions for Europe in Paris
Scandinavian Investment Group A/S17.9.2026 20:52:10 CEST | Pressemeddelelse
Ledende medarbejders handel med aktier
F. Hoffmann-La Roche Ltd17.9.2026 20:30:00 CEST | Press release
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
